Schering-Plough
SGP
#508
Rank
โ‚น4.280 T
Marketcap
N/A
Share price
0.00%
Change (1 day)
N/A
Change (1 year)
Schering-Plough was a major American pharmaceutical company that developed and marketed a range of prescription drugs. In 2009, Schering-Plough was acquired by Merck & Co. in a $41 billion USD deal.

Revenue for Schering-Plough (SGP)

Revenue in 2008: โ‚น1.714 Trillion

In 2008 the company made a revenue of โ‚น1.714 Trillion.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Schering-Plough from 1996 to 2008

Annual revenue

Year Revenue Change
2008โ‚น1.714 T
2006โ‚น981.74 B11.42%
2005โ‚น881.10 B14.94%
2004โ‚น766.56 B-0.74%
2003โ‚น772.31 B-18.13%
2002โ‚น943.38 B3.86%
2001โ‚น908.35 B-0.13%
2000โ‚น909.55 B6.96%
1999โ‚น850.33 B13.61%
1998โ‚น748.49 B19.16%
1997โ‚น628.11 B19.84%
1996โ‚น524.14 B